Genenta Science SpA Sponsored ADR (GNTA) has released an update.
Genenta Science SpA, an Italian biotech firm, has entered into an agreement with Virtu Americas LLC and Capital One Securities, Inc. to sell American Depositary Shares (ADSs) on an ‘at the market’ basis. The company will issue ADSs representing ordinary shares as per the terms set in the agreement and within the limits of authorized but unissued shares. These transactions are to be conducted in compliance with the Securities Exchange Commission regulations, ensuring adherence to the maximum amount permitted under the effective registration statement.
For further insights into GNTA stock, check out TipRanks’ Stock Analysis page.
